Published in Liver on June 01, 1990
Risk of hepatocellular carcinoma in alcoholic cirrhosis. Liver (1991) 0.75
Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med (1993) 4.43
Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med (1997) 3.49
Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study. N Engl J Med (1981) 3.13
Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology (1999) 2.63
Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg (1991) 2.46
Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis (1986) 2.39
Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France. Hepatology (1991) 2.38
Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med (1985) 2.29
Propranolol--a medical treatment for portal hypertension? Lancet (1980) 2.27
Fatal exacerbation of chronic hepatitis B induced by recombinant alpha-interferon. Lancet (1991) 2.14
Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology (1980) 2.02
Ectopic varices in portal hypertension. Clin Gastroenterol (1985) 1.90
Acute hepatic necrosis and fulminant hepatic failure. Gut (1973) 1.87
Second generation (RIBA) test in diagnosis of chronic hepatitis C. Lancet (1991) 1.84
Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders. Gastroenterology (1988) 1.76
A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med (1992) 1.71
Immune complex type glomerulonephritis in cirrhosis of the liver. Am J Pathol (1975) 1.63
Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology (1985) 1.62
Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology (1986) 1.59
Emergency liver transplantation for fulminant hepatitis. Ann Intern Med (1987) 1.56
A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report. Hepatology (1984) 1.56
Expression of complement-regulatory proteins in normal and UW-preserved human liver. Gastroenterology (1994) 1.54
Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology (1991) 1.52
Sclerosing cholangitis induced by formaldehyde solution injected into the biliary tree of rats. Arch Surg (1990) 1.52
Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients. Hepatology (1989) 1.50
A controlled study of therapeutic portacaval shunt in alcoholic cirrhosis. Lancet (1976) 1.49
Peliosis hepatis in recipients of renal transplants. Gut (1978) 1.48
Propranolol in prevention of recurrent gastrointestinal bleeding in cirrhotic patients. Lancet (1981) 1.47
Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C. Ann Intern Med (1997) 1.44
The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study. Hepatology (1982) 1.44
Autoimmune chronic hepatitis exacerbated by alpha-interferon. Ann Intern Med (1992) 1.44
Transvenous liver biopsy: an experience based on 1000 hepatic tissue samplings with this procedure. Gastroenterology (1982) 1.43
Is the response to recombinant alpha interferon related to the presence of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis? J Hepatol (1990) 1.43
Exacerbation of multiple sclerosis after the administration of recombinant human interferon alfa. JAMA (1989) 1.38
Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology (1999) 1.35
Acute intravascular hemolysis and acute liver failure associated as a first manifestation of Wilson's disease. Ann Intern Med (1977) 1.31
Nodular regenerative hyperplasia of the liver. Report of six cases and review of the literature. Gastroenterology (1978) 1.29
Resection of presumed benign liver tumours. Br J Surg (1993) 1.29
Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases. Gut (1992) 1.28
Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology (1996) 1.26
Drug-induced prolonged cholestasis in adults: a histological semiquantitative study demonstrating progressive ductopenia. Hepatology (1992) 1.22
Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet (1991) 1.20
Heterozygous alpha 1-antitrypsin deficiency and cirrhosis in adults, a fortuitous association. Lancet (1975) 1.20
Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria. A spectrum from asymptomatic occlusion of hepatic venules to fatal Budd-Chiari syndrome. Gastroenterology (1987) 1.18
Clinical course of spontaneous reactivation of hepatitis B virus infection in patients with chronic hepatitis B. Hepatology (1990) 1.16
[Hepatitis caused by diclofenac]. Gastroenterol Clin Biol (1983) 1.15
Idiopathic portal hypertension (perisinusoidal fibrosis) after renal transplantation. Gut (1979) 1.15
Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis. J Viral Hepat (2002) 1.14
Portosystemic shunt in Budd-Chiari syndrome: long-term survival and factors affecting shunt patency in 25 patients in Western countries. Surgery (1994) 1.13
Successful endoscopic obturation of gastric varices with butyl cyanoacrylate. Hepatology (1989) 1.13
Perhexiline maleate-induced cirrhosis. Gastroenterology (1979) 1.12
Portal hypertension in fulminant viral hepatitis. Gut (1980) 1.12
The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study. Hepatology (1993) 1.12
Side-to-side portacaval shunt in the treatment of Budd-Chiari syndrome. Gastroenterology (1975) 1.12
Hepatic granulomas and hepatic sarcoidosis. Clin Liver Dis (2000) 1.12
Mechanism for reduced drug clearance in patients with cirrhosis. Gastroenterology (1978) 1.10
Comparison of the effects of a cardioselective and a nonselective beta-blocker on portal hypertension in patients with cirrhosis. Hepatology (1982) 1.09
Inhibition by colchicine of fibrinogen translocation in hepatocytes. J Cell Biol (1975) 1.08
Epithelioid hemangioendothelioma of the liver. Diagnostic features and role of liver transplantation. Gastroenterology (1988) 1.07
Amodiaquine-induced hepatitis. A report of seven cases. Ann Intern Med (1986) 1.07
Pulmonary hypertension complicating portal hypertension. Am Rev Respir Dis (1979) 1.07
MR imaging in intracystic hemorrhage of simple hepatic cysts. Abdom Imaging (1993) 1.07
Amodiaquine-induced fulminant hepatitis. J Hepatol (1988) 1.05
Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study. Gastroenterology (1986) 1.05
Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis C. Clin Biochem (2001) 1.03
Hepatic venous outflow block caused by short-length hepatic vein stenoses. Hepatology (1997) 1.02
Right-sided endocarditis complicating peritoneovenous shunting for ascites. Arch Intern Med (1983) 1.02
[Critical study of current treatment of acute hepatic insufficiency]. Rev Fr Etud Clin Biol (1969) 1.01
Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial. J Hepatol (1988) 1.01
The ultrastructure of hepatocytes in alpha-1-antitrypsin deficiency with the genotype Pi--. Gut (1975) 1.01
Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg. J Hepatol (1997) 1.00
Predictors of sustained response to alpha interferon therapy in chronic hepatitis C. J Hepatol (1998) 1.00
Hepatic sarcoidosis with portal hypertension. A report of seven cases with a review of the literature. Q J Med (1987) 1.00
Idiopathic biliary ductopenia in adults: a report of five cases. Gastroenterology (1990) 0.99
[Partial nodular transformation of the liver with portal hypertension]. Presse Med (1967) 0.99
[Biliary secretion of rabbit: evidence in favor of important fraction independent of bile salts]. Rev Fr Etud Clin Biol (1969) 0.99
Transvenous (transjugular) liver biopsy. An experience based on 100 biopsies. Am J Dig Dis (1978) 0.99
Effect of surgery under general anaesthesia on antipyrine clearance. Br J Clin Pharmacol (1978) 0.98
Predictors of sustained response to alpha interferon therapy in chronic hepatitis C. Clin Biochem (1999) 0.98
Ketoconazole-induced fulminant hepatitis. Gut (1985) 0.97
Cross hepatotoxicity between tricyclic antidepressants. Gut (1986) 0.97
The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology (1994) 0.97
Caustic sclerosing cholangitis. A complication of the surgical treatment of hydatid disease of the liver. Arch Surg (1986) 0.96
Pyrazinamide fulminant hepatitis: an old hepatotoxin strikes again. Lancet (1981) 0.95
Interleukin-6: an early marker of bacterial infection in decompensated cirrhosis. J Hepatol (1994) 0.95
Arterialization of the liver wh portacaval shunt in the treatment of portal hypertension due to intrahepatic block. Surgery (1970) 0.95
Hepatocyte ultrastructural changes in alpha1-antitrypsin deficiency. Gastroenterology (1974) 0.94
Albumin synthesis by human liver cells: its morphological demonstration. Gastroenterology (1972) 0.93
Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin Endocrinol (Oxf) (1993) 0.93
Hepatitis B core antigen in hepatocytes of patients with chronic active hepatitis. Dig Dis Sci (1980) 0.93
Liver transplantation for protoporphyria. Evidence for the predominant role of the erythropoietic tissue in protoporphyrin overproduction. Gastroenterology (1988) 0.93
Shaving as potential source of hepatitis C virus infection. Lancet (1995) 0.92
Portal hypertension and ascites in acute hepatitis: clinical, hemodynamic and histological correlations. Hepatology (1989) 0.92
Isoniazid-rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction. Gastroenterology (1977) 0.92
Portal vein thrombosis with ruptured oesophageal varices as presenting manifestation of hereditary protein C deficiency. Gut (1988) 0.92
Non-Hodgkin's lymphoma presenting as a primary tumor of the liver: presentation, diagnosis and outcome in eight patients. Hepatology (1991) 0.92
Life-threatening hemorrhage of the digestive tract in cirrhotic patients. An assessment of the postoperative mortality after emergency portacaval shunt. Am J Surg (1976) 0.92
[Effects of novobiocin on the functioning of the liver. II. Experimental study]. Rev Fr Etud Clin Biol (1967) 0.92